Chromatine/Épigénétique
Les inhibiteurs de la chromatine/épigénétique sont des composés qui modulent la structure et la fonction de la chromatine ou interfèrent avec les modifications épigénétiques, telles que la méthylation de l'ADN et la modification des histones. Ces inhibiteurs sont des outils essentiels pour étudier la régulation de l'expression génique et le rôle de l'épigénétique dans des maladies telles que le cancer, les troubles neurologiques et les anomalies du développement. En ciblant les processus épigénétiques, ces inhibiteurs peuvent modifier les schémas d'expression génique et offrir de nouvelles perspectives thérapeutiques. Chez CymitQuimica, nous offrons une large sélection d'inhibiteurs de la chromatine/épigénétique de haute qualité pour soutenir vos recherches en biologie moléculaire, génétique et épigénétique.
Sous-catégories appartenant à la catégorie "Chromatine/Épigénétique"
2235 produits trouvés pour "Chromatine/Épigénétique"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
BRD4-BD1-IN-1
CAS :<p>BRD4-BD1-IN-1 (Compound 9a) is a BRD4-BD1 inhibitor(IC50= 38.20 μM).</p>Formule :C16H15BrN4O4Couleur et forme :SolidMasse moléculaire :407.22A2AAR/HDAC-IN-1
CAS :<p>A2AAR/HDAC-IN-1 (compound 14c) is an orally active, balanced A2AAR/HDAC dual inhibitor of A2AAR (Ki: 163.5 nM), HDAC1 (IC50: 145.3 nM). effect.</p>Formule :C24H21N7O2Couleur et forme :SolidMasse moléculaire :439.47ARTD10/PARP10-IN-2
CAS :<p>ARTD10/PARP10-IN-2: A potent, non-selective PARP inhibitor, IC50: ARTD10/PARP10 (2.0μM), ARTD1/PARP1 (9.7μM).</p>Formule :C12H13N3O3Couleur et forme :SolidMasse moléculaire :247.25BNS
CAS :<p>BNS is a potent, prolyl-hydroxylase 2 (PHD2)-selective inhibitor.</p>Formule :C18H16N2O6S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :420.46MARK-IN-4
CAS :<p>MARK-IN-4 inhibits microtubule kinase (MARK) effectively (IC50: 1 nM), a target for Alzheimer's therapy.</p>Formule :C21H23N7OSCouleur et forme :SolidMasse moléculaire :421.52DCE_42
CAS :<p>DCE_42 is a novel EZH2 inhibitor, it also displays significant anti-proliferation activity against lymphoma cell lines.</p>Formule :C22H19N9O2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :473.51JAK-IN-11
CAS :<p>JAK-IN-11 (R-348) is a potent and selective inhibitor of JAK, has the potential for the skin disorders treatment.</p>Formule :C23H22FN5O4SDegré de pureté :99.75%Couleur et forme :SolidMasse moléculaire :483.52PARP1-IN-9
CAS :<p>PARP1-IN-9, potent PARP1 inhibitor with 30.51 nM IC50, outperforms Olaparib in anticancer efficacy.</p>Formule :C18H21N3O5Couleur et forme :SolidMasse moléculaire :359.38BRD4 Inhibitor-25
<p>BRD4 Inhibitor-25 blocks BRD4 (BD1: IC50 0.82 μM, BD2: 1.94 μM), induces cell death in ovarian cancer, used in cancer research.</p>Formule :C29H27N5O6SCouleur et forme :SolidMasse moléculaire :573.62CAY10685
CAS :<p>CAY10685, a CPTH2 analog with an alkyne for click reactions, inhibits NAT10 to study cancer-related chromatin changes.</p>Formule :C17H16ClN3SCouleur et forme :SolidMasse moléculaire :329.85DNMT3A-IN-1
CAS :<p>DNMT3A-IN-1 is a potent, selective DNMT3A inhibitor with KI 9.16-18.85 μM (AdoMet) and 11.37-23.34 μM (poly dI-dC).</p>Formule :C30H38N6O4Couleur et forme :SolidMasse moléculaire :546.66NCDM-32B
CAS :<p>NCDM-32B, a novel potent and selective KDM4 inhibitor, impairs viability and transforms phenotypes of basal breast cancer.</p>Formule :C15H30N2O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :302.41AChE/HDAC-IN-1
CAS :<p>COX-2-IN-23 (A10) inhibits AChE & HDAC (IC50s: 0.12 & 0.23 nM), has antioxidant/metal-binding traits, and is used in Alzheimer's research.</p>Formule :C26H27ClN4O3Couleur et forme :SolidMasse moléculaire :478.97TYK2-IN-11
CAS :<p>TYK2-IN-11 (5B) selectively inhibits TYK2 (IC50: 0.016 nM) and JAK1 (IC50: 0.31 nM), aiding autoimmune and inflammatory disease research.</p>Formule :C18H17N5O3SCouleur et forme :SolidMasse moléculaire :383.42SGC6870
CAS :<p>SGC6870 is a novel potent, selective, and cell-active inhibitor of PRMT6 with IC50 of 77 ± 6 nM, being selective over all other PRMTs and 23 methyltransferases.</p>Formule :C23H21BrN2O2SCouleur et forme :SolidMasse moléculaire :469.39BRD4 Inhibitor-26
<p>BRD4 Inhibitor-26: blocks BRD4 (BD1 and BD2) with IC50 of 0.82 μM & 1.94 μM; used in ovarian cancer research.</p>Formule :C29H27N5O6SCouleur et forme :SolidMasse moléculaire :573.62103D5R
CAS :<p>103D5R selectively inhibits hif-1α, reducing its levels in hypoxia or with cobalt ions, dose- and time-dependently.</p>Formule :C20H21N3O2Couleur et forme :SolidMasse moléculaire :335.4MAT2A-IN-6
CAS :<p>MAT2A-IN-6 inhibits MAT2A, may slow MTAP-deficient cancer cell growth, has research value in cancer.</p>Formule :C18H13ClF3N3O3Couleur et forme :SolidMasse moléculaire :411.76CP-690550A
CAS :<p>Cp-690550a is a novel JAK3 inhibitor, which is used to treat rheumatoid arthritis, graft rejection, psoriasis, and other immune-mediated diseases.</p>Formule :C15H21N5O2Couleur et forme :SolidMasse moléculaire :303.36MZ-242
CAS :<p>MZ-242 is an effective and selective inhibitor of Sirt2.</p>Formule :C24H27N7O3S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :525.65Antiproliferative agent-17
CAS :<p>Antiproliferative Agent-17 exhibits both antimicrobial properties against Gram-positive bacteria and anticancer activity [1].</p>Formule :C26H28N2OSCouleur et forme :SolidMasse moléculaire :416.58KDOAM-25
CAS :<p>KDOAM-25, a potent KDM5 inhibitor, enhances H3K4 methylation, hampers MM1S cell growth; IC50: 71 nM (5A), 19 nM (5B), 69 nM (5C/D).</p>Formule :C15H25N5O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :307.39HDAC6/8/BRPF1-IN-1
CAS :<p>HDAC6/8/BRPF1-IN-1 is a cancer-research inhibitor for HDAC6, HDAC8, BRPF1 with IC50: 344-908 nM and Kd: 175.2 nM.</p>Formule :C18H17N3O5SCouleur et forme :SolidMasse moléculaire :387.41UNC2327
CAS :<p>UNC2327 is a potent and selective inhibitor of protein arginine methyltransferase 3 (PRMT3) (IC50:230 nM).</p>Formule :C14H17N5O2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :319.38AA-CW236
CAS :<p>AA-CW236 is a covalent inhibitor of human O(6)-alkylguanine DNA methyltransferase (MGMT).</p>Formule :C17H16ClF3N4O2Couleur et forme :SolidMasse moléculaire :400.78NN-390
CAS :<p>NN-390: selective HDAC6 inhibitor, IC50 9.8 μM, blood-brain barrier penetrant, potential for metastatic group 3 neural tube cancer research.</p>Formule :C17H16F4N2O4SCouleur et forme :SolidMasse moléculaire :420.38EZH2-IN-9
CAS :<p>EZH2-IN-9 inhibits EZH2, targeting SET mutations linked to cancer by reducing H3K27me3 levels.</p>Formule :C28H32ClF2N3O5SCouleur et forme :SolidMasse moléculaire :596.09EZH2-IN-11
CAS :<p>EZH2-IN-11, a potent E2HZ inhibitor with potential for cancer treatment, is highlighted in patent WO2019204490A1.</p>Formule :C28H36ClN3O5SCouleur et forme :SolidMasse moléculaire :562.12Aurora Kinases-IN-2
CAS :<p>Aurora Kinases-IN-2 (12Aj) hinders Aurora A/B kinases (IC50: 90/152 nM), used in cancer studies.</p>Formule :C22H18ClN5O3Couleur et forme :SolidMasse moléculaire :435.86DC-BPi-11
CAS :<p>DC-BPi-11 inhibits BPTF at IC50 698 nM and significantly reduces leukemia cell growth.</p>Formule :C20H23N5O2SCouleur et forme :SolidMasse moléculaire :397.49JS1310
CAS :<p>JS1310 is a selective PRMT7 inhibitor (IC50: 5 μM against human PRMT7). JS1310 has shown anti-cancer effects on different cancer cells.</p>Formule :C23H22FN5O3Couleur et forme :SolidMasse moléculaire :435.45CypD inhibitor C-9
CAS :<p>CypD inhibitor C-9 is a CypD inhibitor, it attenuates mitochondrial and cellular perturbation insulted by Aß and calcium stress.</p>Formule :C22H22N4O4S2Couleur et forme :SolidMasse moléculaire :470.56BET-IN-2
CAS :<p>BET-IN-2 is a BET inhibitor (IC50: 52 nM for BRD4-BD1).</p>Formule :C23H29N3ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :363.5PIM1-IN-6
CAS :<p>PIM1-IN-6 (5h) inhibits PIM-1 (IC50: 0.60 μM) and is cytotoxic to HCT-116 (IC50: 1.51 μM) and MCF-7 cells (IC50: 15.2 μM).</p>Formule :C21H18N6O4Couleur et forme :SolidMasse moléculaire :418.41TNKS-IN-41
CAS :<p>TNKS-IN-41 highly potent and selective inhibitor of tankyrase.</p>Formule :C24H22N10O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :482.5K00135
CAS :<p>K00135 (IMIDAZOPYRIDAZIN 1) is a selective inhibitor of Pim kinases and can be used in studies about gastric cancer and antileukemic therapeutics.</p>Formule :C18H18N4ODegré de pureté :98.16%Couleur et forme :SolidMasse moléculaire :306.36MC-1353
CAS :<p>MC-1353 is a potent, selective inhibitor of HDAC class I.</p>Formule :C16H16N2O3Couleur et forme :SolidMasse moléculaire :284.31PBRM1-BD2-IN-1
CAS :<p>PBRM1-BD2-IN-1: Selective PBRM1 inhibitor with Kd 0.7μM, IC50 0.2μM, useful in cancer research.</p>Formule :C17H19ClN2OCouleur et forme :SolidMasse moléculaire :302.84-iodo-SAHA
CAS :<p>4-Iodo-SAHA (1k), an oral HDAC inhibitor for cancer research, has EC50s from 0.12 to 1.3 μM across various cell lines.</p>Formule :C14H19IN2O3Couleur et forme :SolidMasse moléculaire :390.22HDAC1-IN-4
CAS :<p>HDAC1-IN-4 is a potent inhibitor of Plasmodium falciparum HDAC1 (PfHDAC1) with low cytotoxicity and antimalarial effects (IC50<5 nM).</p>Formule :C21H24BrClN6O2Couleur et forme :SolidMasse moléculaire :507.82JAK-IN-20
CAS :<p>JAK-IN-20: potent oral JAK1,2,3 inhibitor with IC50s 7, 5, 14 nM respectively, good pharmacokinetics, anti-inflammatory in vivo.</p>Formule :C28H30FN7O2Couleur et forme :SolidMasse moléculaire :515.58PIM1-IN-7
CAS :<p>PIM1-IN-7 inhibits PIM-1 (IC50: 0.67μM), toxic to HCT-116/MCF-7 cells (IC50: 42.9/7.68μM).</p>Formule :C23H23N5OCouleur et forme :SolidMasse moléculaire :385.46HDAC/CK2-IN-1
CAS :<p>HDAC/CK2-IN-1 (compound 38) acts as an inhibitor of HDAC1 (IC 50 = 1.46 μM), HDAC6 (IC 50 = 0.66 μM), and CK2 (IC 50 = 3.67 μM). It demonstrates promising antiproliferative effects on various cell lines, including Jurkat, MCF-7, HCT-116, and HL-60.</p>Formule :C15H18Br4N4O2Couleur et forme :SolidMasse moléculaire :605.95BRD4-BD1/2-IN-1
CAS :<p>BRD4-BD1/2-IN-1 efficiently blocks BRD4 BD-1/2 under 100 nM IC50 (US20150148375A1, cmpd 5).</p>Formule :C21H14F2N4O2Couleur et forme :SolidMasse moléculaire :392.36DPQ
CAS :<p>DPQ inhibits PARP-1, aids in neuroprotection, restores ATP, and lessens neuronal injury from NMDA.</p>Formule :C18H26N2O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :302.41AMPK activator 9
CAS :<p>AMPK activator 9 (ZM-6) is a potent α2β1γ1 agonist with an EC50 of 1.1 µM, potential for type 2 diabetes research.</p>Formule :C31H28F4N4O4Couleur et forme :SolidMasse moléculaire :596.57ART-IN-1
CAS :<p>ART-IN-1 (compound 7) is a selective inhibitor of PARP with IC 50 s of 19, 22, 2.4, >100, 1.1 μM for PARP2, TNKS2, PARP10, PARP14, PARP15, respectively [1].</p>Formule :C14H13NO2SCouleur et forme :SolidMasse moléculaire :259.32Peficitinib hydrochloride
CAS :<p>Peficitinib HCl (ASP015K) is an oral JAK inhibitor with IC50s: JAK1 (3.9 nM), JAK2 (5.0 nM), JAK3 (0.7 nM), Tyk2 (4.8 nM).</p>Formule :C18H23ClN4O2Couleur et forme :SolidMasse moléculaire :362.86VE-465
CAS :<p>VE-465 is an inhibitor of Aurora kinase, which involves in multiple mitotic events.</p>Formule :C22H28N8OSCouleur et forme :SolidMasse moléculaire :452.58PRMT5-IN-17
CAS :<p>PRMT5-IN-17 is a PRMT5-blocking compound with anticancer properties, linked to epigenetic changes.</p>Formule :C26H33N7O2Couleur et forme :SolidMasse moléculaire :475.59HDAC/NAMPT-IN-1
CAS :<p>HDAC/NAMPT-IN-1 (compound 39h) simultaneously inhibits HDAC and NAMPT, exhibiting IC 50 values ranging from 0.72 to 37081 nM for HDAC and 1618 nM for NAMPT [1].</p>Formule :C19H21N5O2Couleur et forme :SolidMasse moléculaire :351.4IACS-9571 hydrochloride
CAS :<p>IACS-9571 hydrochloride: potent TRIM24/BRPF1 inhibitor; IC50 = 8 nM (TRIM24); Kd = 31 nM (TRIM24), 14 nM (BRPF1).</p>Formule :C32H43ClN4O8SCouleur et forme :SolidMasse moléculaire :679.22KDM2B-IN-4
CAS :<p>KDM2B-IN-4, from patent WO2016112284A1 as 182b, is a potent KDM2B inhibitor used in cancer research.</p>Formule :C24H28N2O2Couleur et forme :SolidMasse moléculaire :376.49CEP-8983
CAS :<p>CEP-8983 is a PARP inhibitor potentially for the treatment of solid tumours.</p>Formule :C18H14N2O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :306.32BRM/BRG1 ATP Inhibitor-4
CAS :<p>BRM/BRG1 ATP Inhibitor-4, a potent inhibitor of BRG1/BRM, is utilized in the research of cancers and BAF complex-related disorders.</p>Formule :C25H32N6O3SCouleur et forme :SolidMasse moléculaire :496.62MAT2A-IN-7
CAS :<p>MAT2A-IN-7 inhibits MAT2A in various cancers, especially MTAP-deficient cancer cells, with potential for research use.</p>Formule :C17H13ClF3N3O2Couleur et forme :SolidMasse moléculaire :383.75Dihydro-5-azacytidine acetate
CAS :<p>Dihydro-5-azacytidine acetate (DHAC), a nucleoside analog, becomes integrated into DNA, thereby inhibiting DNA methylation, and exhibits antitumor activity [1</p>Formule :C10H18N4O7Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :306.27LT052
CAS :<p>LT052 is a BET BD1 inhibitor with anti-inflammatory activity. It mediates the BRD4/NF-κB/NLRP3 signaling inflammatory pathway.</p>Formule :C22H19N5O4SDegré de pureté :98.82%Couleur et forme :SolidMasse moléculaire :449.48Sirt2-IN-6
CAS :<p>Sirt2-IN-6 is a potent and selective inhibitor of SIRT2 (IC50: 0.815 μM) and can be used to study cancer.</p>Formule :C26H26N6O3SCouleur et forme :SolidMasse moléculaire :502.59BRD4884
CAS :<p>BRD4884 is a highly selective and efficient HDAC1 and HDAC2 inhibitor that also inhibits HDAC3, used in research on neurological disorders.</p>Formule :C18H19FN2O2Degré de pureté :99.19% - 99.21%Couleur et forme :SolidMasse moléculaire :314.35Lorpucitinib
CAS :<p>Lorpucitinib (JNJ-64251330) is a JAK kinase inhibitor used in the study of inflammatory and gastrointestinal diseases.</p>Formule :C22H28N6O2Degré de pureté :99.72%Couleur et forme :SolidMasse moléculaire :408.5KDM2/7-IN-1
CAS :<p>KDM2/7-IN-1 is a selective histone demethylase inhibitor (IC50s: 0.2–>120 μM) that inhibits HeLa and KYSE-150 cell proliferation, epigenetic and cancer.</p>Formule :C15H27NO4Degré de pureté :99.87%Couleur et forme :SolidMasse moléculaire :285.38BETi-211
CAS :<p>BETi-211 is a selective inhibitor BET bromodomain.</p>Formule :C26H29N7O3Couleur et forme :SolidMasse moléculaire :487.55ZYJ-25e
CAS :<p>ZYJ-25e is an oral histone deacetylase inhibitor (HDACi) with potent antitumor activities.</p>Formule :C30H40N4O8Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :584.66IND 1316
CAS :<p>IND 1316 is an activator of AMP-activated protein kinase (AMPK).</p>Formule :C22H17NO3Couleur et forme :SolidMasse moléculaire :343.38CCT077791
CAS :<p>CCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.</p>Formule :C9H5ClN2O3SDegré de pureté :98.60%Couleur et forme :SolidMasse moléculaire :256.67ZIKV-IN-2
CAS :<p>ZIKV-IN-2 blocks ZIKV replication, is a strong NS5 MTase inhibitor (IC50: 38.86 μM), and aids Zika virus research.</p>Formule :C39H42O4Couleur et forme :SolidMasse moléculaire :574.75KU-0058684
CAS :<p>KU-0058684 is a potent PARP and DNA-PK inhibitors.</p>Formule :C19H14FN3O3Couleur et forme :SolidMasse moléculaire :351.33ML753286
CAS :<p>ML753286 has high permeability and low to medium clearance in rodent and human liver S9 fractions.</p>Formule :C20H25N3O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :355.43Trotabresib
CAS :<p>Trotabresib (CC-90010) is an orally active inhibitor of BET and can be used in studies about advanced solid tumors.</p>Formule :C21H21NO4SDegré de pureté :99.86%Couleur et forme :SolidMasse moléculaire :383.46JAK1-IN-4
CAS :<p>JAK1-IN-4 selectively blocks JAK1 (IC50 = 85 nM) over JAK2/JAK3 and halts STAT3 phosphorylation in NCI-H 1975 cells (IC50 = 227 nM).</p>Formule :C26H32FN9O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :521.59Y02224
CAS :<p>Y02224 is a BET inhibitor. It shows the reasonable antiproliferative effect on leukemia cells.</p>Formule :C20H17BrN2O4SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :461.33Dot1L-IN-5
CAS :<p>Dot1L-IN-5 is a potent inhibitor of the disruptor of telomeric silencing 1-like protein ( DOT1L ) with an IC 50 SPA DOT1L of 0.17 nM [1].</p>Formule :C23H19ClF2N8O5SCouleur et forme :SolidMasse moléculaire :592.96HAT-IN-1
CAS :<p>HAT-IN-1 is an inhibitor of HAT used in the research of cancer.</p>Formule :C23H18BrF4N3O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :556.3Helenalin Acetate
CAS :<p>Helenalin Acetate: anti-inflammatory, anti-cancer, hinders C/EBPß and p300 cooperation.</p>Formule :C17H20O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :304.34HDAC-IN-45
CAS :<p>HDAC-IN-45, a small HDAC blocker, forms H-bonds with Y303 and shows anticancer properties; IC50 for HDAC1/2/3: 0.108/0.585/0.563 μM.</p>Formule :C25H20ClFN8OCouleur et forme :SolidMasse moléculaire :502.93DM-01
CAS :<p>DM-01 is a potent and selective inhibitor of EZH2.</p>Formule :C23H24F3N3O2Couleur et forme :SolidMasse moléculaire :431.45dBRD9-A
CAS :<p>Potent BRD9 degrader that binds selectively, fully degrades BRD9 at low doses, and hinders synovial sarcoma growth in vitro and in mice.</p>Formule :C42H49N7O8Couleur et forme :SolidMasse moléculaire :779.88PB118
<p>PB118 clears Aβ, boosts phagocytosis, enhances tubulin networks, reduces p-tau & inflammation in AD; HDAC6 IC50: 5.6 nM.</p>Formule :C18H19FN2O2Couleur et forme :SoildMasse moléculaire :314.35Dot1L-IN-7
CAS :<p>Dot1L-IN-7 (compound 25), a potent DOT1L inhibitor with an IC50 of 1.0 μM, selectively kills MLL-AF9, sparing E2A-HLF cells.</p>Formule :C23H27N9O2Couleur et forme :SolidMasse moléculaire :461.52CeMMEC2
CAS :<p>CeMMEC2, a novel inhibitor of BRD4, binds both the first and the second bromodomain of BRD4.</p>Formule :C14H19N5Couleur et forme :SolidMasse moléculaire :257.33(1S,2R)-Tranylcypromine hydrochloride
CAS :<p>(1S,2R)-Tranylcypromine hydrochloride ((1S,2R)-SKF 385), a potent antidepressant, functions by inhibiting both MAO and LSD1.</p>Formule :C9H12ClNCouleur et forme :SolidMasse moléculaire :169.651Guadecitabine sodium
CAS :<p>Guadecitabine sodium is a inhibitor of second-generation DNA methyltransferases (DNMT) .</p>Formule :C18H24N9NaO10PDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :580.407HDAC6-IN-46
CAS :<p>HDAC6-IN-46 (compound 12) is a selective inhibitor of histone deacetylase 6 (HDAC6), exhibiting an IC50 of 6.2 nM. It is utilized in research related to Alzheimer's disease.</p>Formule :C26H21N3O4Couleur et forme :SolidMasse moléculaire :439.46HDAC3-IN-T326
CAS :<p>HDAC3-IN-T326: potent, selective HDAC3 inhibitor, boosts NF-κB acetylation, activates latent HIV gene expression.</p>Formule :C21H18N6O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :434.47Gue1654
CAS :<p>Gue1654 is an OXE-R inhibitor and cardiomyocyte apoptosis.Gue1654 can be used for the study of cardiovascular diseases.</p>Formule :C23H17N3OS3Degré de pureté :98.02% - 98.04%Couleur et forme :SolidMasse moléculaire :447.6LSD1-IN-6
CAS :<p>LSD1-IN-6, a potent LSD1 inhibitor (IC50: 123 nM), enhances H3K4me2 without altering LSD1 expression. Reversible.</p>Formule :C15H13BrN2O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :349.18SC-9
CAS :<p>SC-9 is a protein kinase C activator.</p>Formule :C22H24ClNO2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :401.95PS432
CAS :<p>PS432 inhibits atypical PKCs, targets PIF-pocket, reduces tumors in mice sans side effects.</p>Formule :C25H19ClN2O5SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :494.95SMYD2-IN-1
CAS :<p>SMYD2-IN-1 is an inhibitor of SMYD2 (IC50 of 4.45 nM).</p>Formule :C25H25Cl2F2N7O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :564.41Piribedil dihydrochloride
CAS :<p>dopamine agonist</p>Formule :C16H20Cl2N4O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :371.26Akt Inhibitor X
CAS :<p>Akt Inhibitor X is a cell-permeable and reversible inhibitor of Akt phosphorylation.</p>Formule :C20H25ClN2ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :344.88KDM5B-IN-3
CAS :<p>KDM5B-IN-3 inhibits KDM5B/JARID1B with IC50 of 9.32 μM, useful in gastric cancer studies.</p>Formule :C19H25ClN4O2Couleur et forme :SolidMasse moléculaire :376.88DDP-38003 dihydrochloride
CAS :<p>DDP-38003 dihydrochloride is an orally available histone lysine-specific demethylase 1A (KDM1A/LSD1) inhibitor (IC50: 84 nM).</p>Formule :C21H28Cl2N4ODegré de pureté :99.76%Couleur et forme :SolidMasse moléculaire :423.38CID-4785700
CAS :<p>CID-4785700 is a potent pan-GTPase inhibitor that inhibits Rab7 and inhibits the fungal histone acetyltransferase Rtt109 that binds to Asf1 and Vps75</p>Formule :C22H23ClFN3O3Degré de pureté :98.16%Couleur et forme :SolidMasse moléculaire :431.89Kgp-IN-1
CAS :<p>Kgp-IN-1 is an arginine-specific gingipain (Rgp) inhibitor.</p>Formule :C19H24F4N4O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :432.41PARP-1/2-IN-1
CAS :<p>PARP-1-/2-IN-1 is a potent inhibitor of PARP-1 (IC50: 0.51 nM) and PARP-2 (IC50: 23.11 nM).</p>Formule :C24H27FN4O3Couleur et forme :SolidMasse moléculaire :438.49NSC-636819
CAS :<p>NSC-636819 is a novel inhibitor of KDM4A/KDM4B.</p>Formule :C22H12Cl4N2O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :510.15M-110
CAS :<p>M-110 selectively targets PIM kinases, best at PIM-3 (IC50=47nM), and inhibits prostate cancer cell growth (IC50=0.6-0.9μM).</p>Formule :C22H28ClN5O3Degré de pureté :99.55%Couleur et forme :SolidMasse moléculaire :445.94MI-1
CAS :<p>MI-1 inhibits Menin-MLL interaction with an IC 50 of 1.9 μM [1].</p>Formule :C19H25N5S2Couleur et forme :SolidMasse moléculaire :387.57
